What companies are GRAL's competitors?

GRAIL Inc. (GRAL)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.

How does GRAL compare to its peers?

The peer comparison table on this page shows GRAIL Inc. (GRAL) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.

What sector does GRAL operate in?

GRAIL Inc. (GRAL) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.

GRAL

GRAIL Inc.

NASDAQ·Biotechnology · Healthcare

$70.66$2.05−2.82%

After hours·$70.66+0.00%

Market cap$3.03B·Market closed·Jul 22 8:00 PM UTC

Frequently Asked Questions About GRAL

What companies are GRAL's competitors?: GRAIL Inc. (GRAL)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does GRAL compare to its peers?: The peer comparison table on this page shows GRAIL Inc. (GRAL) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does GRAL operate in?: GRAIL Inc. (GRAL) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.

GRAL

GRAIL Inc.

NASDAQ·Biotechnology · Healthcare

$70.66$2.05−2.82%

After hours·$70.66+0.00%

Market cap$3.03B·Market closed·Jul 22 8:00 PM UTC

Peers


APGE	Apogee Therapeutics, Inc.	$134.08	$8.3B
CNTA	Centessa Pharmaceuticals plc	$40.50	$6.3B
XENE	Xenon Pharmaceuticals Inc.	$66.18	$5.2B
CELC	Celcuity Inc.	$90.14	$4.4B
NVST	Envista Holdings Corp	$26.43	$4.3B
DYN	Dyne Therapeutics, Inc.	$23.21	$3.8B
IDYA	IDEAYA Biosciences, Inc.	$35.00	$3.3B
SLNO	Soleno Therapeutics, Inc.	$53.01	$2.8B
RARE	Ultragenyx Pharmaceutical Inc.	$27.65	$2.7B
AAPG	Ascentage Pharma Group International	$19.24	$1.8B

Frequently Asked Questions About GRAL

What companies are GRAL's competitors?: GRAIL Inc. (GRAL)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does GRAL compare to its peers?: The peer comparison table on this page shows GRAIL Inc. (GRAL) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does GRAL operate in?: GRAIL Inc. (GRAL) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.